Descriptor English: | Albuterol, Ipratropium Drug Combination | ||||
Descriptor Spanish: |
Combinación Albuterol y Ipratropio
| ||||
Descriptor Portuguese: | Combinação Albuterol e Ipratrópio | ||||
Descriptor French: | Association de bromure d'ipratropium et de salbutamol | ||||
Entry term(s): |
Albuterol Ipratropium Albuterol Ipratropium Drug Combination Albuterol-Ipratropium Albuterol-Ipratropium Drug Combination Combination, Albuterol-Ipratropium Drug Combination, Dey Combivent Combivent Respimat Dey Combination Drug Combination, Albuterol-Ipratropium Respimat, Combivent |
||||
Tree number(s): |
D02.033.100.291.057.125 D02.092.063.291.057.125 D02.092.471.683.061.125 D02.145.074.722.229.400.500 D03.132.760.180.572.400.500 D03.132.889.180.648.400.500 D03.605.084.500.722.229.400.500 D03.605.869.229.400.500 D26.310.344 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000068600 | ||||
Scope note: | A combined pharmaceutical preparation of Ipratropium Bromide and Albuterol Sulfate that is used to treat the symptoms of ASTHMA and CHRONIC OBSTRUCTIVE PULMONARY DISEASE. |
||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||
Public MeSH Note: | 2016; ALBUTEROL-IPRATROPIUM was indexed under ALBUTEROL 1999-2015, and under IPRATROPIUM 1999-2015 |
||||
History Note: | 2016 (1999) |
||||
DeCS ID: | 55857 | ||||
Unique ID: | D000068600 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 2016/01/01 | ||||
Date of Entry: | 2015/07/01 | ||||
Revision Date: | 2016/05/27 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds -
CHEMICALS AND DRUGS
Pharmaceutical Preparations [D26]Pharmaceutical Preparations
|
Albuterol, Ipratropium Drug Combination
- Preferred
Combivent Respimat
- Narrower
Dey Combination
- Narrower
Combivent
- Narrower
Concept UI |
M0299247 |
Scope note | A combined pharmaceutical preparation of Ipratropium Bromide and Albuterol Sulfate that is used to treat the symptoms of ASTHMA and CHRONIC OBSTRUCTIVE PULMONARY DISEASE. |
Preferred term | Albuterol, Ipratropium Drug Combination |
Entry term(s) |
Albuterol Ipratropium Albuterol Ipratropium Drug Combination Albuterol-Ipratropium Albuterol-Ipratropium Drug Combination Combination, Albuterol-Ipratropium Drug Drug Combination, Albuterol-Ipratropium |
Concept UI |
M000603239 |
Preferred term | Combivent Respimat |
Entry term(s) |
Respimat, Combivent |
Concept UI |
M0299246 |
Preferred term | Dey Combination |
Entry term(s) |
Combination, Dey |
Concept UI |
M0523139 |
Preferred term | Combivent |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey